Rosiglitazone might improve β-cell function in patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2007年 / 3卷 / 6期
关键词：
D O I：
10.1038/ncpendmet0464
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：442 / 442
相关论文
共 50 条
  • [1] Rosiglitazone improves β-cell function as measured by proinsulin/insulin ratio in patients with type 2 diabetes
    Porter, LE
    Freed, MI
    Jones, NP
    Biswas, N
    [J]. DIABETES, 2000, 49 : A122 - +
  • [2] Biliary Jejunostomy Might Improve Glucose in Type 2 Diabetes Patients
    Ning Zhang
    Weijie Chen
    Haixin Yin
    Wei Liu
    Xiaodong He
    [J]. Obesity Surgery, 2020, 30 : 1446 - 1451
  • [3] Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus
    Vrablik, Michal
    Dobiasova, Milada
    Stulc, Tomas
    Kasalova, Zdislava
    Dolezalova, Radka
    Prazny, Martin
    Fait, Tomas
    Ceska, Richard
    [J]. NEUROENDOCRINOLOGY LETTERS, 2008, 29 (01) : 146 - 150
  • [4] Biliary Jejunostomy Might Improve Glucose in Type 2 Diabetes Patients
    Zhang, Ning
    Chen, Weijie
    Yin, Haixin
    Liu, Wei
    He, Xiaodong
    [J]. OBESITY SURGERY, 2020, 30 (04) : 1446 - 1451
  • [5] Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin
    Naka, Katerina K.
    Papathanassiou, Katerina
    Bechlioulis, Aris
    Pappas, Konstantinos
    Kazakos, Nikolaos
    Kanioglou, Chryssanthi
    Papafaklis, Michail I.
    Kostoula, Aggeliki
    Vezyraki, Patra
    Makriyiannis, Demetrios
    Tsatsoulis, Agathocles
    Michalis, Lampros K.
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (03): : 195 - 201
  • [6] Rosiglitazone decreases insulin resistance and improves beta-cell function in patients with type 2 diabetes.
    Matthews, DR
    Bakst, A
    Weston, WM
    Hemyari, P
    [J]. DIABETOLOGIA, 1999, 42 : A228 - A228
  • [7] Rosiglitazone reduces proinsulin/insulin ratio and improves β-cell function in type 2 diabetes
    Porter, LE
    Freed, MI
    Jones, NP
    Biswas, N
    [J]. DIABETOLOGIA, 2000, 43 : A192 - A192
  • [8] Effect of rosiglitazone versus insulin on the pancreatic β-cell function of subjects with type 2 diabetes
    Ovalle, F
    Bell, DSH
    [J]. DIABETES CARE, 2004, 27 (11) : 2585 - 2589
  • [9] Rosiglitazone improves postprandial glycaemia and markers of endothelial function in patients with Type 2 diabetes
    Agrawal, A
    Chen, H
    Yan, Y
    Mather, R
    Albertini, JP
    Valensi, P
    Hanefeld, M
    [J]. DIABETOLOGIA, 2002, 45 : A251 - A251
  • [10] Rosiglitazone does not adversely affect cardiac structure or function in patients with type 2 diabetes
    Sutton, MS
    Dole, JF
    Rappaport, EB
    [J]. DIABETES, 1999, 48 : A102 - A102
12345